Changing the status of drugs from prescription to over-the-counter availability.
about
Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industryPatterns and predictors of self-medication in northern UgandaConsumer knowledge of over-the-counter phenazopyridine.Usage patterns of over-the-counter phenazopyridine (pyridium).The safety of drugs for OTC use: what evidence is required for an NSAID switch?Pre and post-interventional pattern of self medication in three common illnesses in staff of a tertiary hospitalWidening consumer access to medicines: a comparison of prescription to non-prescription medicine switch in Australia and New Zealand.Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sampleWillingness-to-accept pharmaceutical retail inconvenience: evidence from a contingent choice experimentEconomic evaluations of neuraminidase inhibitors to control influenza.Results of a national survey on over-the-counter medicines, Part 1: Pharmacist opinion on current scheduling status.Should cholesterol-lowering medications be available in Canada without a prescription?How much time does it take to prescribe a new medication?Estimating Consumers' Knowledge and Attitudes Towards Over-The-Counter Analgesic Medication in Greece in the Years of Financial Crisis: The Case of Paracetamol.Where to buy OTC medications? A cross-sectional survey investigating consumers' confidence in over-the-counter (OTC) skills and their attitudes towards the availability of OTC painkillersThe gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making.Prescription and nonprescription drug use in isfahan, Iran: An observational, cross-sectional study.The influence of need for cognition and principal display panel factors on over-the-counter drug facts label comprehension.Improving the decision-making process for nonprescription drugs: a framework for benefit-risk assessment.A decision-analysis tool for benefit-risk assessment of nonprescription drugs.Asthma medications should be available for over-the-counter use: pro.Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.U.S. pharmacy policy: a public health perspective on safety and cost.Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.Time Trends in Physician Visits for Gastroesophageal Reflux Disease Before and After the Rx-to-OTC Switch of Proton Pump Inhibitors.Use of prescribed and non-prescribed medication for dyspepsia.Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use.Therapeutic and economic consequences of OTC loratadine.Non-prescription medicines and Australian community pharmacy interventions: rates and clinical significance.Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany.Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon.The value of self-medication: summary of existing evidence.Abuse of over-the-counter medicines: a pharmacist's perspective.Over-the-counter medicine use prior to and during hospitalization.Rational use of paracetamol among out-patients in a Bhutanese district hospital bordering India: a cross-sectional study
P2860
Q26747042-272D2F14-4C6F-4289-8CDB-DA7FAED8661BQ28541309-1E8DB8B6-9E32-4FDF-BACA-C9C14471B7C4Q34628473-86E63A5B-9A42-4373-8DAE-9AF6A2ED0D7EQ34741374-A9F109AF-5691-4184-9C42-AF34DD44BA59Q35014449-64B20C56-256E-4442-AC1D-C90A0C36562FQ35040307-958E2263-39BC-42F8-B58F-F5BBCF082544Q35191920-25B10766-9A1E-4A3E-AAC1-78A8ED6D3C8EQ35538593-1468B133-7370-4F52-9DE0-BE246B1FB555Q35665612-4429B9CB-A906-416A-98A9-43EDDC526AB4Q36020202-52627856-E18F-42FD-9106-6388B58C2F31Q36595925-A11706DD-4E9F-4996-82E6-4AE567E2A978Q36755379-41A7091D-E2A1-4EEE-9208-262C236D92DFQ36970584-ECE84273-FC50-4DE7-88C2-D552AE364F1BQ37018613-26FB9BF8-A53A-4975-A707-796CC6148AEBQ37208421-204C913D-2F4A-494F-93E8-1080CFF2E2FBQ37654695-3BC05E86-EFD7-4522-8750-76C1D30364D8Q37672711-C615DE81-F35D-4448-B128-BF932FE77BC0Q37928673-9052571F-DA5A-49AD-B817-E5135A2DC1DFQ37952076-04CE3FDC-9644-4D4D-8D7C-FC5229FA17A8Q38079175-264A210B-182D-4268-93A1-FBCC2E42AEC9Q38223151-E3EDB2F7-58CF-4162-BEC2-98271EE6B911Q39766133-8B937899-DE24-41B3-A838-18BE877D736BQ39939660-3E0DC3C8-68F9-4BB5-A2B6-37CB808729B0Q40052369-A7E7B28E-41BB-46DF-B03E-926D0D6B7B95Q40269291-54958BB8-AAFF-4344-89E4-D1917099DAE8Q40593163-E801FA6C-1BED-4197-B22A-C16D3AE2EBE8Q42636045-FC97B5BE-B2DC-4639-87EF-0E5ECA0996FAQ43437545-3C09C458-F949-4CF8-B613-F3BBAFC64758Q44741661-9CD7C73F-9F35-4796-805D-EBFFEEF31B11Q45752450-CF57F7C3-8DAC-4AB5-A7C4-C1F31D4AB944Q46683768-F49B6B94-B4AC-4759-AC41-EB0994401CA3Q46945037-7340CF63-5FC9-4A9C-A686-21806E2E600CQ47830747-5986CCD7-80E7-4B38-9080-EE08E3D1E3A3Q49257872-5A23340D-C133-408C-95D5-D16AA8BD7269Q50137087-EC838B24-D50E-4CF9-879A-64DB785E1116Q58755039-03513383-A5C4-47DF-95CE-2C72D68664AC
P2860
Changing the status of drugs from prescription to over-the-counter availability.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Changing the status of drugs from prescription to over-the-counter availability.
@ast
Changing the status of drugs from prescription to over-the-counter availability.
@en
Changing the status of drugs from prescription to over-the-counter availability.
@nl
type
label
Changing the status of drugs from prescription to over-the-counter availability.
@ast
Changing the status of drugs from prescription to over-the-counter availability.
@en
Changing the status of drugs from prescription to over-the-counter availability.
@nl
prefLabel
Changing the status of drugs from prescription to over-the-counter availability.
@ast
Changing the status of drugs from prescription to over-the-counter availability.
@en
Changing the status of drugs from prescription to over-the-counter availability.
@nl
P356
P1476
Changing the status of drugs from prescription to over-the-counter availability.
@en
P2093
P304
P356
10.1056/NEJMRA011080
P407
P577
2001-09-01T00:00:00Z